Controlling EVA in the 21st century: ‘zero tolerance’ or ‘live and let live’?

At the time of writing in August 2007, when foot and mouth disease virus (FMDV) has apparently escaped from biologically secure research or vaccine production facilities to nearby cattle in the UK and bluetongue virus (BTV) continues to infect livestock in its second season after over-wintering in northern Europe, the importance of controlling infectious diseases of animals through measures such as ‘heightened surveillance’, ‘optimal biosecurity’ and ‘vaccination’ is firmly in the dual spotlights of scientific and public scrutiny. Although they may not obviously or directly affect horses, these latest livestock disease outbreaks should act as an important alarm call to the equine veterinary and research communities for vigilance and preparedness to deal with equivalent situations in the equine species. To this end, since March 2007 the UK equine welfare charity, The Horse Trust, has been campaigning to raise awareness and develop contingency planning for the threat to the UK and Europe from African horse sickness virus, a highly fatal midge-borne infection of horses that is closely related to BTV. At the same time as we have seen the re-emergence of these high profile outbreaks of infection by FMDV and BTV, the potentially economically and clinically important infectious disease equine viral arteritis (EVA) (Timoney and McCollum 1990) has been recognised since late June 2007 among non-Thoroughbred horses in France (International Collating Centre, Newmarket). At the time of writing 16 equine premises in Normandy had been identified with infection with equine arteritis virus (EAV), with many of the cases being clinically apparent and clear epidemiological links between most outbreaks identified. The EVA outbreak currently unfolding in France acts as a timely backdrop for this commentary, which in considering approaches to control of EVA hopes that, as with all outbreaks, lessons can be learned so that not only are diseases dealt with effectively when they occur but that they may actually be prevented through measured and affordable actions.

[1]  Jianqiang Zhang,et al.  The outcome of vaccinating five pregnant mares with a commercial equine viral arteritis vaccine , 2007 .

[2]  J. Gilkerson,et al.  Evidence-based immunization in horses. , 2007, The Veterinary clinics of North America. Equine practice.

[3]  U. Balasuriya,et al.  Differentiation of strains of equine arteritis virus of differing virulence to horses by growth in equine endothelial cells. , 2003, American journal of veterinary research.

[4]  G. Horner Equine Viral Arteritis , 2003 .

[5]  J. Wood,et al.  Serological surveillance of equine viral arteritis in the United Kingdom since the outbreak in 1993 , 1999, Veterinary Record.

[6]  P. Timoney,et al.  A perspective on equine viral arteritis (infectious arteritis of horses). , 1996, Revue scientifique et technique.

[7]  A. Higgins,et al.  First recorded outbreak of equine viral arteritis in the United Kingdom , 1995, Veterinary Record.

[8]  E. D. Chirnside Equine arteritis virus: An overview , 1992, British Veterinary Journal.

[9]  P. Timoney,et al.  A longitudinal study of equine arteritis virus infection in Standardbred stallions with special reference to occurrence of the carrier state , 1992 .

[10]  P. Timoney,et al.  Equine viral arteritis: current clinical and economic significance , 1990 .

[11]  P. Timoney,et al.  Equine viral arteritis — epidemiology and control , 1988 .

[12]  J. Traub-Dargatz,et al.  Equine viral arteritis at a veterinary teaching hospital , 1987 .

[13]  P. Timoney,et al.  The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of virus transmission. , 1987, Journal of reproduction and fertility. Supplement.

[14]  R. F. Hall,et al.  Transmissibility and abortogenic effect of equine viral arteritis in mares. , 1986, Journal of the American Veterinary Medical Association.

[15]  P. Timoney,et al.  Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. , 1986, Research in veterinary science.

[16]  R. Bowen,et al.  Vaccination of stallions with a modified live equine viralarteritis virus , 1986 .

[17]  J. Bryans,et al.  Serological Identification of Infection by Equine Arteritis Virus in Horses of Several Countries1 , 1974 .

[18]  J. Bryans,et al.  Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. , 1968, The Cornell veterinarian.

[19]  J. Bryans,et al.  An outbreak of abortion caused by the equine arteritis virus. , 1957, The Cornell veterinarian.